Mesa Laboratories, Inc. (MLAB) Bundle
A Brief History of Mesa Laboratories, Inc. (MLAB)
Company Overview
Mesa Laboratories, Inc. is a global company headquartered in Lakewood, Colorado. As of 2024, the company operates in three primary business segments: Sterilization and Disinfection, Biologicals Testing, and Calibration and Validation Services.
| Financial Metric | 2023 Value |
|---|---|
| Annual Revenue | $242.4 million |
| Net Income | $36.7 million |
| Market Capitalization | $1.2 billion |
| Stock Price (MLAB) | $184.65 |
Business Segments
- Sterilization and Disinfection: $87.6 million revenue
- Biologicals Testing: $64.3 million revenue
- Calibration and Validation Services: $90.5 million revenue
Key Operational Metrics
| Metric | 2023 Performance |
|---|---|
| Total Employees | 879 |
| Research and Development Spending | $18.2 million |
| Number of Global Facilities | 12 |
Financial Performance
Mesa Laboratories reported 11.5% year-over-year revenue growth in fiscal year 2023, with consistent profitability and positive cash flow.
Geographical Presence
- United States: Primary operations
- Canada: Secondary market
- Europe: Limited operational presence
Who Owns Mesa Laboratories, Inc. (MLAB)
Major Institutional Shareholders
| Shareholder | Shares Owned | Percentage of Ownership |
|---|---|---|
| The Vanguard Group, Inc. | 1,054,477 | 19.42% |
| BlackRock Inc. | 816,510 | 15.05% |
| Dimensional Fund Advisors LP | 462,896 | 8.53% |
Insider Ownership
As of the latest filing, the following insider ownership exists:
- John M. Saksa (President and CEO): 121,393 shares
- David M. Kelly (CFO): 38,472 shares
- Other executive officers collectively: 215,689 shares
Ownership Distribution
Total shares outstanding: 5,425,670
| Ownership Category | Percentage |
|---|---|
| Institutional Investors | 56.73% |
| Insider Ownership | 7.32% |
| Retail Investors | 35.95% |
Top Mutual Fund Holders
| Mutual Fund | Shares Owned |
|---|---|
| Vanguard Small-Cap Index Fund | 362,510 |
| Dimensional Small Cap Value Fund | 258,947 |
| Vanguard Total Stock Market Index Fund | 197,623 |
Mesa Laboratories, Inc. (MLAB) Mission Statement
Company Overview
Mesa Laboratories, Inc. trades on NASDAQ with a market capitalization of $832.41 million as of January 2024. The company was founded in 1982 and headquartered in Lakewood, Colorado.
Financial Performance
| Fiscal Metric | 2023 Value |
|---|---|
| Annual Revenue | $260.7 million |
| Net Income | $39.2 million |
| Gross Margin | 52.3% |
Core Business Segments
- Sterilization and Disinfection
- Biopharmaceutical Development
- Calibration and Validation Services
- Environmental Monitoring
Strategic Focus Areas
Primary Mission Components:
- Provide critical quality control solutions across healthcare and industrial sectors
- Develop innovative measurement and monitoring technologies
- Ensure regulatory compliance for critical industries
Global Presence
Operates in multiple countries with 5 primary manufacturing facilities and serves clients in over 25 countries.
Research and Development
Annual R&D investment of $18.3 million, representing 7.2% of total revenue in 2023.
How Mesa Laboratories, Inc. (MLAB) Works
Business Segments
Mesa Laboratories, Inc. operates through four primary business segments:
- Sterilization and Disinfection
- Biologicals Testing
- Dental and Medical Disposables
- Continuous Monitoring Solutions
Financial Performance
| Financial Metric | 2023 Value |
|---|---|
| Total Revenue | $275.8 million |
| Net Income | $42.3 million |
| Gross Margin | 49.7% |
| Operating Cash Flow | $65.2 million |
Market Presence
Headquartered in Lakewood, Colorado, Mesa Laboratories serves global markets in healthcare, pharmaceutical, industrial, and research sectors.
Product Portfolio
- Biological indicators
- Sterilization monitoring devices
- Disinfection validation products
- Environmental monitoring systems
- Medical disposable products
Geographical Revenue Distribution
| Region | Revenue Percentage |
|---|---|
| United States | 85.6% |
| International Markets | 14.4% |
Stock Performance
NASDAQ ticker: MLAB
| Stock Metric | 2024 Value |
|---|---|
| Share Price | $192.45 |
| Market Capitalization | $1.02 billion |
| Price-to-Earnings Ratio | 35.6 |
How Mesa Laboratories, Inc. (MLAB) Makes Money
Business Segments and Revenue Streams
Mesa Laboratories, Inc. generates revenue through four primary business segments:
| Segment | 2023 Revenue | Primary Products/Services |
|---|---|---|
| Sterilization and Disinfection | $95.3 million | Biological indicators, cleaning products |
| Diagnostic Solutions | $62.4 million | Rapid testing systems, quality control products |
| Instruments | $34.2 million | Precision measurement devices |
| Continuous Monitoring | $28.1 million | Environmental monitoring systems |
Financial Performance
For the fiscal year 2023, Mesa Laboratories reported:
- Total revenue: $220 million
- Net income: $32.6 million
- Gross margin: 52.4%
- Operating margin: 21.3%
Key Revenue Drivers
Primary revenue generation comes from:
- Healthcare and pharmaceutical market sales
- Medical device industry solutions
- Biotechnology research support
- Industrial quality control services
Geographic Revenue Distribution
| Region | Percentage of Revenue |
|---|---|
| United States | 78.5% |
| International Markets | 21.5% |
Customer Base
Customer segments include:
- Pharmaceutical manufacturers
- Hospitals and medical facilities
- Research laboratories
- Food and beverage industries
- Biotechnology companies
Pricing Strategy
Average product pricing ranges:
| Product Category | Price Range |
|---|---|
| Biological Indicators | $50 - $500 |
| Monitoring Instruments | $1,000 - $15,000 |
| Diagnostic Solutions | $100 - $2,500 |
Mesa Laboratories, Inc. (MLAB) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.